I did all the calculations one more time for

New Post Public Reply Private Reply Replies (4) Message Board
polkadot

I did all the calculations one more time for confirmation.

First thing first though where is this number 100mg/kg in mice before p21 expression noted because I can not find it. I do see studies where they did 200/mg/kg mice and measuring the amount of P21 expression @ 6hr and 16hr. At 6hr the expression was 3x that of controls and at 16hr it was 5x that of controls. Likely because of some form of cascading pathway so what affect this may have at 24hr, etc.. is not yet known to us and we would need to consider clearance and half-life of the drug.

If we do use the 100mg/kg in mice as the first expression of p21 in the studies then I can agree with an equivalent in human. My calculation is 308 mg/m/m so thats spot on. I think I would like to see where that 100 number came from because p21 expression may actually be at a much lower dose.

For DLT comparisons:

NOAEL in mice was 90mg/kg or 277.5mg/m/m in human

NOAEL in dog was 5mg/kg (although symptoms were mild) which is 26.43mg/m/m in humans

With a caveat on these because the doses were given 5x weekly (clearance and half-life issues here!!) and the goal for this kind of study is just to find out the toxicity thats it. So they pumped um full of drugs to find that out.

Also and what everyone seems to be missing is p21 is not the only indicator of efficacy. They say it a PROBABLE that p21 expression means p53 activation.

They could also be seeing tumor reduction which is tested verses baseline at 2mo,4mo,6mo.

They are also testing at least 5 tumor markers for reduction in serum markers verses baseline at 1mo,2mo,3mo,4mo,5mo,6mo.

What I never understood was this idea that they just happened to do p21 biomarkers early when it specifically states in the protocol that the patients would be tested verses baseline at 7hr and 24 hr after EACH dose. A facility such as this has immediate access to qpcr equipment and the department costs are likely around $200 per test with a couple hour turn around if it is sent to another part of the facility but I would bet a couple pennies that there is a machine within five minute walk of their unit. There is not a cancer research facility in this country without one.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating Hit and Run Protocols in St. Tammany Parish

Updated Category News Views 2

When the Driver Disappears: Steps Forward Hit and run accidents can leave you feeling abandoned and unsure of what to do. In St. Tammany Parish, this scenario is all too familiar. Personal Injury Attorney Ross F. Lagarde cuts through the chaos, offering a clear path for those caught in this nightmare, explained in HelloNation's comprehensive guide. Prioritize Safety and...

Continue Reading
GoLive Streamers: A Social Media Wild Card

Updated Category News Views 6

Stepping Boldly into the Livestreaming Arena There's a new kid in the chaotic neighborhood of social media, and it's called GoLive Streamers. Not just another aimless stroll down Content Highway, GoLive is weaving its own defining path by fostering genuine real-time interaction. Launched in April 2026, this plucky platform has quickly amassed a following of over 74,000...

Continue Reading
Hi-Tech's Dubai Chocolate Adds Flavor to Sales Surge

Updated Category News Views 4

Ever found a protein shake that tastes like a candy bar from the future? Well, Hi-Tech Pharmaceuticals is banking on their new Dubai Chocolate flavor to hit that sweet spot. This isn't your typical powdered shake game; Hi-Tech's been cranking the flavor dial ever since they introduced their Precision Protein® line back in 2016. They've carved out a niche with unique...

Continue Reading
Decision Logic Innovates with Vitals & ShiftFlow Tools

Updated Category News Views 2

Restaurant Battlefields: The Need for Real-Time Response Running a restaurant is no walk in the park. One slip, and you're dealing with spoiled soup or crabby customers. Decision Logic reckons they've cracked the code to smoother operations with their new tools, Vitals and ShiftFlow. At heart, these products do one thing: put critical data into the hands of managers while...

Continue Reading
SACHEU Partners with AI to Harness Real Customer Insights

Updated Category News Views 4

Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...

Continue Reading
Flux Expands AI Platform to Prove Engineering ROI

Updated Category News Views 6

Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...

Continue Reading
Riverside Theatre Appoints Seasoned CFO for Growth Phase

Updated Category News Views 6

Change Is Afoot at Riverside Theatre Down in Vero Beach, amid the sun-drenched coziness of Florida’s Treasure Coast, something’s cooking that has nothing to do with sunshine: Riverside Theatre snagged itself a new Chief Financial Officer. As nonprofits go, this one’s not a backyard operation—it’s the largest independent professional theatre in the entire state....

Continue Reading
Synopsys-TSMC Collaboration Drives AI System Evolution

Updated Category News Views 3

Synopsys and TSMC: The New Power Couple in AI Ah, the world of semiconductors—where the chips are small but the stakes are colossal. Once again, Synopsys and TSMC have thrown their hats into the ring, diving headfirst into yet another ambitious collaboration. Their latest mission? To fast-track the evolution of AI systems through a suite of innovations strapped to...

Continue Reading
First Lady Steals NYSE Show, Investors Eye Stakes

Updated Category News Views 3

Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...

Continue Reading
Apex Dental's Growth Shines in Inc. 5000 Ranking

Updated Category News Views 4

Another Year, Another Milestone for Apex Dental Let's talk about steady growth. Apex Dental Partners has made it onto the Inc. 5000 list for the eighth straight year, landing at No. 3,850. Quite a feat, considering this list only features America's fastest-growing private companies. Apex isn't just maintaining its position out of sheer luck. Revenue shot up by 67% over...

Continue Reading

Top 5 Most Recently Viewed Articles

Grayscale Investments Unveils Innovative XRP Trust for Investors

Updated Category News Views 73

Grayscale Investments Launches Grayscale XRP Trust Grayscale Investments, a well-known asset management firm specializing in digital currencies, is excited to announce the public launch of its Grayscale XRP Trust. This new offering provides a unique opportunity for investors to gain exposure to XRP, the cryptocurrency underpinning the XRP Ledger (XRPL). The XRPL is a...

Continue Reading
Citi Maintains Neutral Outlook on Nasdaq Shares with Growth Potential

Updated Category News Views 61

So, Citi kept its Neutral rating on Nasdaq Inc. back in 2024, setting a price target of $70. You know how it goes—when you chat with company brass like President Tal Cohen, sometimes it sways analysts' thoughts. That meeting kicked up some optimism about Nasdaq’s growth path—sure, they threw around terms like 'structural catalysts' and 'cross-selling opportunities'....

Continue Reading
Discover Luxury Living at The Diamond Exchange Building

Updated Category News Views 193

Discover the Unique Charm of The Diamond Exchange Building The former Diamond Exchange located at 14 Maiden Lane has undergone a magnificent transformation. This historic site is just steps away from Wall Street and stands as a testament to New York City's rich architectural history. Once a pinnacle of commerce where every diamond entering the United States was traded, it...

Continue Reading
Innofactor Plc Corrects Transaction Date for CEO Share Transfer

Updated Category News Views 83

Innofactor Plc: Important Update on Managers’ Transactions Innofactor Plc has released an important update concerning its managers’ transactions, particularly focusing on Chief Executive Officer Sami Ensio. This update reflects an amendment in a previous communication regarding the specific execution date of a share transfer. Clarification of Share Transfer Date On a...

Continue Reading
How Passport Is Revolutionizing Parking Management in Cities

Updated Category News Views 229

Transforming Urban Parking: Passport's Role in City Management Passport is leading the charge in innovative parking management technology across bustling cities. As a partner with numerous destination cities, they focus on easing congestion and improving parking efficiency, especially during peak seasons, such as spring break. The Spring Break Surge and Its Challenges...

Continue Reading